In this sense, the platelet-derived growth factor receptor alpha (PDGFRA) gene is directly targeted by miR-34a in this cancer type, thus constituting a negative feedback regulatory loop that results in GB progression [107]. This evidence concerns the gene PDGFRA and cancer.